Christian Pilarsky

27PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersChemotherapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 16, 2025
Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.

Bin Lan, Siyuan Zeng, Shuman Zhang

|Oct 09, 2025
CRISPR-Cas9 screening reveals G2E3 as a novel ubiquitin-linked factor controlling autophagosome-lysosome fusion and cancer cell progression.

Yumei Gong, Marc Leon, Huaqing Mo

|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma.

Katharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer

|Mar 13, 2025
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC.

Elena Fiorini, Antonia Malinova, Daniel Schreyer

|Jul 22, 2024
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.

Camino Bermejo-Rodriguez, Joaquín Araos Henríquez, Giuseppina Caligiuri

|Mar 09, 2024
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.

Shuman Zhang, Duo Yun, Hao Yang

Pageof 5

Frequent Collaborators

3 joint publications

Nathalie Britzen-Laurent

3 joint publications

Bin Lan

3 joint publications

Benjamin Frey

3 joint publications

Mukhopadhyay Debabrata